Neurobiology of Disease

Papers
(The H4-Index of Neurobiology of Disease is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Estrogen-related receptor gamma is a regulator of mitochondrial, autophagy, and immediate-early gene programs in spiny projection neurons: Relevance for transcriptional changes in Huntington disease175
The predictive value of mBDNF for major adverse cardiovascular events in stable coronary artery disease patients with depressive symptoms: A single-center, 5-year follow-up study157
The neoliberal leaning of the neuroscience discourse when it deals with mental health and learning disorders125
Alterations in beta oscillatory activity occur with the emergence of parkinsonian motor signs across the basal ganglia-thalamocortical network114
Cellular iron deposition patterns predict clinical subtypes of multiple system atrophy112
New perspectives on the role of biological factors in anorexia nervosa: Brain volume reduction or oxidative stress, which came first?102
Gut-brain axis in the pathogenesis of sepsis-associated encephalopathy101
Brain organoid models for studying the function of iPSC-derived microglia in neurodegeneration and brain tumours98
Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration88
Diagnostic and prognostic value of the RUNXOR/RUNX1 axis in multiple sclerosis85
Inflammation in dementia with Lewy bodies81
Evoked resonant neural activity in subthalamic local field potentials reflects basal ganglia network dynamics77
Identification of an epilepsy-linked gut microbiota signature in a pediatric rat model of acquired epilepsy74
Nicotinamide riboside modulates the reactive species interactome, bioenergetic status and proteomic landscape in a brain-region-specific manner69
Stem cell therapy for central nervous system disorders: Metabolic interactions between transplanted cells and local microenvironments69
Aberrant splicing of mutant huntingtin in Huntington's disease knock-in pigs68
Interhemispheric reactivity of the subthalamic nucleus sustains progressive dopamine neuron loss in asymmetrical parkinsonism67
Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progression66
Postnatal Foxp2 regulates early psychiatric-like phenotypes and associated molecular alterations in the R6/1 transgenic mouse model of Huntington's disease66
MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers64
Intermittent fasting produces antidepressant-like effects by modulating dopamine D1 receptors in the medial prefrontal cortex63
The altered sensitivity of acute stress induced anxiety-related behaviors by modulating insular cortex-paraventricular thalamus-bed nucleus of the stria terminalis neural circuit61
Amyloid beta peptides (Aβ) from Alzheimer's disease neuronal secretome induce endothelial activation in a human cerebral microvessel model61
Serotonin innervation of the subthalamic nucleus in parkinsonian monkeys61
Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition60
Key role of the gut–microbiota–brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain60
CCR5 deficiency normalizes TIMP levels, working memory, and gamma oscillation power in APOE4 targeted replacement mice60
T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease59
A novel mouse model of chronic neuronopathic Gaucher disease exhibits Parkinson's disease-like phenotypes58
Corrigendum to “Isoflurane on brain inflammation” [Neurobiology of Disease, 62 (2014) Pages 365–371]58
Cogwheel rigidity in Parkinson's disease: Clinical, biomechanical and neurophysiological features57
Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model57
Sphingosine 1-phosphate receptor subtype 1 (S1P1) activity in the course of Alzheimer's disease57
Multimodal imaging of glymphatic dysfunction and retinal vascular changes as biomarkers for Alzheimer's disease56
B cell depletion modulates glial responses and enhances blood vessel integrity in a model of multiple sclerosis55
14-3-3θ phosphorylation exacerbates alpha-synuclein aggregation and toxicity55
Neuronal MeCP2 in the dentate gyrus regulates mossy fiber sprouting of mice with temporal lobe epilepsy53
Exo-miR-144-3p as a promising diagnostic biomarker for depressive symptoms in heart failure53
Direct conversion of human umbilical cord mesenchymal stem cells into dopaminergic neurons for Parkinson's disease treatment53
Early suppression of excitability in subcortical band heterotopia modifies epileptogenesis in rats53
Structural and functional abnormalities in thalamic neurons following neocortical focal status epilepticus52
Neuronal hyperexcitability and ion channel dysfunction in CDKL5-deficiency patient iPSC-derived cortical organoids51
Corrigendum to “Upregulation of tripeptidyl-peptidase 1 by 3-hydroxy-(2,2)-dimethyl butyrate, a brain endogenous ligand of PPARα: Implications for late-infantile Batten disease therapy” [Neurobiology 50
Hippocampal seizures differentially modulate locus coeruleus activity and result in consistent time-locked release of noradrenaline in rat hippocampus50
Early whole-body mutant huntingtin lowering averts changes in proteins and lipids important for synapse function and white matter maintenance in the LacQ140 mouse model49
Alternative platelet activation pathways and their role in neurodegenerative diseases49
Cell type- and region-specific translatomes in an MPTP mouse model of Parkinson's disease49
Reducing the lipase LIPE in mutant α-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism48
Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease48
Molecular pathogenesis of subretinal fibrosis in neovascular AMD focusing on epithelial-mesenchymal transformation of retinal pigment epithelium48
0.49526500701904